Reaction
Guttate Psoriasis reporting signals
As of the last recalculation, Guttate Psoriasis appears in 814 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% (PRR 24.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Triamcinolone Acetonide Ointment Usp, 0.05% | 22 | 24.7 | 24.7 |
| Secukinumab | 126 | 23.4 | 23.5 |
| Ketoconazole Foam | 11 | 19.3 | 19.3 |
| Ketoconazole Cream, 2% | 11 | 19.2 | 19.2 |
| Triamcinolone Acetonide | 22 | 18.7 | 18.7 |
| Ustekinumab | 53 | 14.1 | 14.1 |
| Ixekizumab | 15 | 10.5 | 10.5 |
| Guselkumab | 10 | 7.2 | 7.2 |
| Bimekizumab | 5 | 6.0 | 6.0 |